|
|
Volumn 34, Issue 11, 1998, Pages 973-986
|
|
Pharmacological and clinical profile of valsartan
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID;
AMLODIPINE;
ANGIOTENSIN;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANGIOTENSIN RECEPTOR;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
BENAZEPRIL;
CALCIUM CHANNEL BLOCKING AGENT;
CANDESARTAN;
CIMETIDINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
ENOLTASOSARTAN;
FUROSEMIDE;
HYDROCHLOROTHIAZIDE;
IRBESARTAN;
LACIDIPINE;
LISINOPRIL;
LOSARTAN;
RAMIPRIL;
TASOSARTAN;
UNCLASSIFIED DRUG;
VALSARTAN;
ANTIHYPERTENSIVE ACTIVITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISPOSITION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SAFETY;
DRUG SELECTIVITY;
DRUG TOLERABILITY;
HUMAN;
HYPERTENSION;
REVIEW;
|
|
EID: 0032469761
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.1998.34.11.487481 Document Type: Review |
|
Times cited : (9)
|
|
References (86)
|
